Clinical Specialties

Prostate Cancer

Languages

English , Russian , Spanish , Ukrainian

Education & Training

Smith AJ, Karpova Y, D’Agostino R Jr, Willingham M, Kulik G. Expression of the Bcl-2 protein BAD promotes prostate cancer growth. PLoS ONE. 2009; 4(7):e6224.

Sastry KSR, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, Carson JP, Weber MJ, Register TC, Chen YQ, Penn RB, Kulik G, et al. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem. 2007; 282(19):14094-100.

Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Edwards IJ, D’Agostino R Jr, Chen YQ, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest. 2007; 117(7):1866-1875.

Sastry KSR, Karpova Y, Kulik G. Epidermal growth factor protects prostate cancer cells from apoptosis by inducing BAD phosphorylation via redundant signaling pathways. J Biol Chem. 2006; 281(37):27367-77.

Sastry KSR, Smith AJ, Karpova Y, Datta SR, Kulik G. Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. J Biol Chem. 2006; 281(30):20891-901.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

• WFBMC
• All

For a list of earlier publications, visit the Carpenter Library Publication Search. 

Cancer/oncogenesis , drugs/therapeutic agents pharm , neurosciences/behavior.